JDD WebinarsSkin Barrier Function

Restoring Skin Barrier Function – Why Formulation Matters

By August 5, 2020April 22nd, 2021No Comments

JDD Multimedia

Supported By

Restoring Skin Barrier Function: Why Formulation Matters

With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin.

Tune in as Professor Michael J. Cork BSC MB PhD FRCP and Professor Simon G. Danby discuss the skin-barrier restoring effect of a cream containing ceramides in a multi-vesicular emulsion for people with eczema-prone skin, as well as other skin conditions that require skin-barrier restoration.

FACULTY


Professor Michael J. Cork BSC MB PhD FRCP

Joined the University of Sheffield in 1991 as a lecturer in dermatology whilst continuing as a practising dermatologist for the NHS in Sheffield. Previously, a Registrar in Dermatology at the Royal Hallamshire Hospital, Sheffield, and a Registrar in Respiratory General Medicine at Leeds General Infirmary.

Professor Cork has been closely involved with research in many areas of dermatology; including Atopic Eczema(dermatitis), Psoriasis, Vitiligo and the Genetics of Skin Disease. Major current research work is aimed at identifying gene–environment interactions in the development of atopic dermatitis leading to skin barrier breakdown and the understanding of how topical agents interact with the skin barrier; using this information to enhance the treatment of atopic dermatitis.

Currently the Head of Sheffield Dermatology Research in the Department of Infection, Immunity & Cardiovascular Disease at the University of Sheffield Medical School and Honorary Consultant Dermatologist to both Sheffield Children´s Hospital NHS Foundation Trust and to Sheffield Teaching Hospitals NHS Foundation Trust.


Professor Simon G. Danby PhD, BSC

Originally trained in biochemistry and molecular biology, Professor Danby  joined the University of Sheffield in 2005 as a post-doctoral scientist in the Academic Unit of Biomedical Genetics.

In this position, he worked exclusively for York Pharma on the early stage development of novel therapeutics and diagnostics for atopic dermatitis, psoriasis and malignant melanoma.

In 2009, he joined the Academic Unit of Dermatology Research as a post-doctoral Research Associate. The focus of his research in this role was improving our understanding of the structure and function of the epidermal (skin) barrier and its role in the development of disorders such as atopic dermatitis (AD).

At the beginning of 2012, Professor Danby  was awarded a 3-year unencumbered research fellowship from Johnson & Johnson to continue my research on the skin barrier and set up a dedicated research facility for conducting human skin research.

Since then, he has continued to conduct and lead translational dermatology research as an independent fellow.

Watch On Demand

You May Also Like

New Innovations with SkinCeuticals Cell Cycle Catalyst

| JDD Webinars | No Comments
Supported By   Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. Ted Lain, as he shares information on a new cosmeceutical formulation. This…

Dermatology Roundup: AAD Acne Guidelines; ASA Funding Opportunities

| Acne, Dermatology Roundup, JDD Highlights, JDD in the Media, The Latest | No Comments
By Allison Sit The American Academy of Dermatology (AAD) has updated its guidelines for acne management. The guidelines now include discussion of new topical medications and systemic treatments that were…

Wondering about Words: Evidence Based Framing for Improving Treatment Adherence

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Spotify Hosts: Dr. Adam Friedman and Dr. Steven Feldman Actions speak louder than words…so long as the words inspire, encourage, engage, etc. the actions. This…

Leave a Reply